SHZ:300122

Chongqing Zhifei Biological Products Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:07 UTC

Last close

n/aCNY

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed
    • Computed from the filing for 2025
  • -57.7%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -164.3%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 50.8%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.78Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.0%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    CNY
    • computed

Five bars, one line

lens 7 of 9
0.47x
-7.11x
2.60x
3.36x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales0.47x

    Its own average over 10 years, 18.97B.

  • Profit-7.11x

    Its own average over 10 years, 2.07B.

  • Free cash flow2.60x

    Its own average over 10 years, 1.75B.

  • Debt3.36x

    Its own average over 10 years, 3.65B.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at -7.11 times.

Sales is 0.47 times its own 10-year average; Profit is -7.11 times its own 10-year average; Free cash flow is 2.60 times its own 10-year average; Debt is 3.36 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average0.47
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Profit against its own 10-year average-7.11
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Free cash flow against its own 10-year average2.60
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Debt against its own 10-year average3.36
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    CNY

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.